Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur Arch Psychiatry Clin Neurosci. 2010 Sep;260(6):499-506. doi: 10.1007/s00406-009-0093-2. Epub 2009 Dec 9.

The role of proteomics in depression research.

Author information

  • 1Max Planck Institute for Psychiatry, Kraepelinstr. 2, 80804, Munich, Germany.

Abstract

Depression is a severe neuropsychiatric disorder affecting approximately 10% of the world population. Despite this, the molecular mechanisms underlying the disorder are still not understood. Novel technologies such as proteomic-based platforms are beginning to offer new insights into this devastating illness, beyond those provided by the standard targeted methodologies. Here, we will show the potential of proteome analyses as a tool to elucidate the pathophysiological mechanisms of depression as well as the discovery of potential diagnostic, therapeutic and disease course biomarkers.

PMID:
19997739
[PubMed - indexed for MEDLINE]
PMCID:
PMC2940035
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk